Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Guidance programme
Guidance programme
Clinical guidelines (27)
Diagnostics guidance (7)
Health technology evaluations (17)
HealthTech guidance (14)
Highly specialised technologies guidance (4)
Interventional procedures guidance (11)
Medical technologies guidance (9)
NICE guidelines (30)
Public health guidelines (1)
Technology appraisal guidance (293)
HealthTech approach
HealthTech approach
Early use (3)
Existing use (1)
Interventional procedure (4)
Routine use (2)
Area of interest
Area of interest
COVID-19 (8)
Apply filters
Showing 231 to 240 of 372
Sort by
Title
Date
Apply sorting
Type: Guidance
`Remove $Type: Guidance filter`
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Optical Coherence Tomography to guide percutaneous coronary intervention
Interventional procedures guidance
TBC
Orforglipron for managing overweight and obesity [ID6516]
Technology appraisal guidance
18 November 2026
Osimertinib for maintenance treatment of EGFR mutation-positive unresectable locally advanced non-small-cell lung cancer after platinum-based chemoradiotherapy [ID6223]
Technology appraisal guidance
21 May 2026
Osimertinib for neoadjuvant treatment of EGFR mutation-positive resectable non-small-cell lung cancer [ID6472]
Technology appraisal guidance
TBC
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)
NICE guideline
29 July 2026
Oveporexton for treating type 1 narcolepsy [ID6622]
Technology appraisal guidance
TBC
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]
Technology appraisal guidance
TBC
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]
Technology appraisal guidance
23 July 2026
Patritumab deruxtecan for treating EGFR mutation-positive advanced non-small-cell lung cancer after 1 or 2 tyrosine kinase inhibitor treatment [ID6467]
Technology appraisal guidance
TBC
Peezy Midstream for urine collection (MT446)
Medical technologies guidance
TBC
Previous page
1
…
22
23
Current page
24
25
26
…
38
Page
24
of
38
Next page
Results per page
10
25
50
All
Back to top